Targeting T-cell exhaustion and tumour immune evasion: a review of emerging strategies
{{output}}
Adoptive T-cell therapies and immune checkpoint blockade have produced durable remissions in selected malignancies, yet most patients still fail to achieve lasting benefit. Two convergent obstacles underlie much of this failure: T-cell exhaustion and tumour im... ...
